V. Cheng
Infectious Diseases · Clinical Infectious Diseases · 2007–2022
A researcher in the Science corpus: 10 papers; trusts 1 researcher and is trusted by 4 researchers here, as inferred from the citation graph.
Subfields
- Infectious Diseases — 184 citations into it; #228 of 589 by trust here, #20 by citations
Whom V. Cheng trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts V. Cheng overall
Papers from V. Cheng's perspective
Ordered by how strongly the researchers V. Cheng trusts endorse each paper. Same corpus, a different order for every researcher.
- Identification of a novel coronavirus in patients with severe acute respiratory syndrome. (New England Journal of Medicine)
- A novel coronavirus associated with severe acute respiratory syndrome. (New England Journal of Medicine)
- Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study (The Lancet)
- Koch's postulates fulfilled for SARS virus (Nature)
- Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. (New England Journal of Medicine)
- A major outbreak of severe acute respiratory syndrome in Hong Kong. (New England Journal of Medicine)
- Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China (Science)
- Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage (Journal of Molecular Biology)
- Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection (Gastroenterology)
- Lung pathology of fatal severe acute respiratory syndrome (The Lancet)
Their papers
- Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 (2022) — 1,241 citations
- The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2 (2020) — 781 citations
- Consistent Detection of 2019 Novel Coronavirus in Saliva (2020) — 1,767 citations
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial (2020) — 1,333 citations
- Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens (2020) — 795 citations
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study (2020) — 2,971 citations
- COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing (2020) — 614 citations
- A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster (2020) — 8,316 citations
- Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease (2015) — 811 citations
- Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection (2007) — 998 citations